From a land shaped by ancient civilisations, Iraqi researcher Mayes Ali Hadi Al-Hassany brings together pharmaceutical science, project management and technology. She has a clear goal for investors to get behind: building factories in Iraq that make medicines patients can trust and supply them to markets across the region.
Iraq, 5th Nov 2026 – Together We Build Iraq Mayes Ali Hadi Al-Hassany’s Journey from the Laboratory to a Vision for Iraqi-Made Medicines – Together, we build Iraq. Imagine a pharmacist in Amman or Dubai reaching for a box marked “Made in Iraq.” Behind that box are researchers who developed its formulation, technicians who mastered its production, and a laboratory that verified its quality before it left the factory. This is the scene Mayes Ali Hadi Al-Hassany wants to see become part of Iraq’s future.
Returning to the Classroom
Mayes Al-hassany began her career in pharmacy and went on to pursue research in pharmaceutical science and manufacturing. After gaining experience in the field, she stepped away from pharmacy practice for a time and returned to the classroom to study project management. She wanted to learn how to secure funding for a scientific idea, build the team to carry it out, and use promising laboratory results to make a case for manufacturing to investors.
She attended several international conferences, kept up with developments in Western pharmacy markets, and studied the business models of retailers such as Australia’s Chemist Warehouse, Britain’s Boots and Watsons. What caught her attention was the work behind the shelves. Even before a factory buys its first piece of equipment, demand, product availability and distribution can help determine which medicines are worth making and in what quantities.
From Pharmaceutical Research to the Factory Floor
Mayes Al-hassany completed a series of studies in pharmaceutical science and manufacturing and published her work internationally. Her research included developing a formulation for extended-release metformin tablets and comparing its drug-release profile with that of a reference product. She also studied the stability of amlodipine tablets under hot and humid conditions to understand how formulation and packaging affect the quality of the medicine during storage.
She discussed her work with academics and researchers from universities and research centres in several countries. Some of those who reviewed her studies and discussed them with her expressed admiration for her work. They saw her ability to connect laboratory questions with manufacturing challenges as a sign of what she could contribute to pharmaceutical science in the years ahead.
That connection shapes her vision for Iraqi manufacturing. She wants an Iraqi factory to begin with a carefully chosen product, a team that knows how to maintain its quality, and a system that can trace every batch. Once the factory demonstrates consistent quality and reliable supply, it can pursue registration and distribution in neighbouring markets in line with local requirements.
A Call to Iraqi Investors
Mayes Al-hassany’s message to investors is clear. Invest in pharmaceutical factories in Iraq and in the people who will run and improve them. A single production line backed by a sound feasibility study can give Iraqi researchers a place to put their knowledge to work at home, young technicians a chance to gain industrial experience, and patients access to locally made medicines they can trust.
For Mayes Al-hassany, pride in Iraq’s heritage finds expression in the path she has chosen. She wants to put her knowledge to work for others and bring the questions she learned to ask in the laboratory to the factory floor. When a box of Iraqi-made medicine reaches a pharmacy beyond the country’s borders, the achievement worth celebrating will be the work behind it: the people who turned scientific knowledge into a medicine someone could depend on.
Media Contact
Organization: HQearth
Contact Person: Mayes Ali Alhassany
Website: https://www.hqearth.org/
Email: Send Email
Country: Iraq
Release id: 50485
View source version on King Newswire:
Together We Build Iraq Mayes Ali Hadi Al-Hassany’s Journey from the Laboratory to a Vision for Iraqi-Made Medicines
Ben is the traditionally ascribed author of the Gospel of Mark. Mark is said to have founded the Church of Alexandria, one of the most important episcopal sees of early Christianity. His feast day is celebrated on April 25, and his symbol is the winged lion .
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Daily Michigan News journalist was involved in the writing and production of this article.